Stock analysts at Mitsubishi UFJ Financial Group initiated coverage on shares of Iqvia (NYSE:IQV) in a research note issued on Friday. The brokerage set a “neutral” rating and a $112.00 price target on the medical research company’s stock. Mitsubishi UFJ Financial Group’s target price points to a potential upside of 10.38% from the stock’s current price.

A number of other research analysts also recently commented on the stock. TheStreet raised shares of Iqvia from a “c+” rating to a “b” rating in a research report on Wednesday. KeyCorp reiterated a “sector weight” rating and issued a $100.00 target price on shares of Iqvia in a research note on Friday, November 10th. Morgan Stanley lifted their target price on shares of Iqvia from $96.00 to $121.00 and gave the company an “overweight” rating in a research note on Thursday, November 9th. Mizuho cut shares of Iqvia from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a research note on Thursday, November 9th. Finally, SunTrust Banks reiterated a “hold” rating and issued a $114.00 target price on shares of Iqvia in a research note on Friday, November 3rd. Ten analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $105.61.

Iqvia (NYSE IQV) opened at $101.47 on Friday. Iqvia has a 1 year low of $74.73 and a 1 year high of $110.67. The company has a market cap of $21,260.52, a P/E ratio of 23.34, a P/E/G ratio of 1.63 and a beta of 0.61. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 1.29.

Iqvia (NYSE:IQV) last announced its quarterly earnings data on Thursday, October 26th. The medical research company reported $1.19 EPS for the quarter, beating the Zacks’ consensus estimate of $1.14 by $0.05. Iqvia had a net margin of 0.58% and a return on equity of 12.60%. The firm had revenue of $2.02 billion for the quarter, compared to the consensus estimate of $2.01 billion. During the same period in the previous year, the firm posted $1.00 earnings per share. The firm’s revenue was up 77.6% on a year-over-year basis. equities analysts anticipate that Iqvia will post 4.62 EPS for the current fiscal year.

In related news, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total transaction of $764,776,314.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider James H. Erlinger III sold 10,000 shares of the business’s stock in a transaction on Wednesday, September 27th. The stock was sold at an average price of $94.52, for a total transaction of $945,200.00. Following the transaction, the insider now directly owns 27,340 shares in the company, valued at approximately $2,584,176.80. The disclosure for this sale can be found here. Insiders sold 16,631,093 shares of company stock valued at $1,640,970,687 over the last 90 days. 6.40% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “Iqvia (IQV) Receives New Coverage from Analysts at Mitsubishi UFJ Financial Group” was first published by Watch List News and is owned by of Watch List News. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/iqvia-iqv-receives-new-coverage-from-analysts-at-mitsubishi-ufj-financial-group/1765379.html.

Iqvia Company Profile

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.